Recent investigations showed a higher frequency of CD56bright NK cells during relapse, indicating an immediate response to disease reactivation, while CCR6-related shifts among this population suggest altered ILC migration to the CNS during MS (185). This evidence concerns the gene CCL27 and myeloid sarcoma.